FDA Advises Covid-19 Vaccine Makers to Tackle JN.1 Variant

By Sabela Ojea


The Food and Drug Administration has recommended that manufacturers of Covid-19 vaccines should focus on the JN.1 variant beginning in the fall of 2024.

The FDA's Vaccines...
-June 07, 2024 at 05:45 pm EDT
- MarketScreener

Related Keywords

Sabela Ojea ,Centers For Disease ,Drug Administration ,Products Advisory Committee On ,Related Biological Products Advisory Committee ,Disease Control ,Dow Jones ,